Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
Status:
Recruiting
Trial end date:
2020-05-05
Target enrollment:
Participant gender:
Summary
Glucagon-like peptide-1 receptor (GLP-1R) is a kind of G protein coupled receptor which
regulate the insulin secretion and serves as potential target in the diagnosis of functional
pancreas neuroendocrine tumor. The aim of this study was the clinical evaluation of a
potential GLP-1R targeted tracer 68Ga-NOTA-MAL-Cys39-exendin-4 for the detection of
insulinoma.
Phase:
Early Phase 1
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University